Sfe Investment Counsel Danaher Corp Transaction History

Sfe Investment Counsel

$438 Million
Q2 2024

A detailed history of Sfe Investment Counsel transactions in Danaher Corp stock. As of the latest transaction made, Sfe Investment Counsel holds 15,970 shares of DHR stock, worth $4.31 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares

15,970

Previous 14,635 9.12%

Holding current value

$4.31 Million

Previous $3.65 Million 9.2%

% of portfolio

0.91%

Previous 0.84%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$235.51 - $267.98 $314,405 - $357,753	1,335 Added 9.12%	15,970 $3.99 Million
Q1 2024 May 03, 2024	BUY	$224.58 - $256.19 $441,299 - $503,413	1,965 Added 15.51%	14,635 $3.65 Million
Q4 2023 Jan 31, 2024	BUY	$185.1 - $233.13 $678,391 - $854,421	3,665 Added 40.7%	12,670 $2.93 Million
Q3 2023 Oct 24, 2023	BUY	$233.08 - $265.59 $291,350 - $331,987	1,250 Added 16.12%	9,005 $2.23 Million
Q2 2023 Jul 24, 2023	BUY	$224.99 - $256.14 $338,609 - $385,490	1,505 Added 24.08%	7,755 $1.86 Million
Q1 2023 May 08, 2023	BUY	$239.75 - $277.0 $433,947 - $501,370	1,810 Added 40.77%	6,250 $1.58 Million
Q4 2022 Feb 09, 2023	SELL	$241.42 - $282.29 $62,769 - $73,395	-260 Reduced 5.53%	4,440 $1.18 Million
Q3 2022 Nov 14, 2022	BUY	$247.06 - $1507.4 $40,764 - $248,721	165 Added 3.64%	4,700 $1.21 Million
Q2 2022 Aug 10, 2022	BUY	$237.11 - $299.66 $145,822 - $184,290	615 Added 15.69%	4,535 $1.15 Million
Q1 2022 May 06, 2022	BUY	$257.27 - $315.76 $460,513 - $565,210	1,790 Added 84.04%	3,920 $1.15 Million
Q4 2021 Feb 07, 2022	BUY	$292.08 - $329.01 $410,372 - $462,259	1,405 Added 193.79%	2,130 $701,000
Q3 2021 Nov 12, 2021	BUY	$272.21 - $332.43 $197,352 - $241,011	725 New	725 $221,000

Others Institutions Holding DHR

# of Institutions

2,394

Shares Held

563M

Call Options Held

3.94M

Put Options Held

4.1M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $197B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sfe Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Sfe Investment Counsel with notifications on news.

Account

Sfe Investment Counsel Danaher Corp Transaction History